Loss of articular cartilage due to extracellular matrix breakdown is the hallmark of arthritis. Degradative fragments of cartilage oligomeric matrix protein (COMP), a prominent noncollagenous matrix component in articular cartilage, have been observed in the cartilage, synovial fluid, and serum of arthritis patients. The molecular mechanism of COMP degradation and the enzyme(s) responsible for it, however, remain largely unknown. ADAMTS-12 (a disintegrin and metalloprotease with thrombospondin motifs) was shown to associate with COMP both in vitro and in vivo. ADAMTS-12 selectively binds to only the EGFlike repeat domain of COMP of the four functional domains tested. The four C-terminal TSP-1-like repeats of ADAMTS-12 are shown to be necessary and sufficient for its interaction with COMP. Recombinant ADAMTS-12 is capable of digesting COMP in vitro. The COMP-degrading activity of ADAMTS-12 requires the presence of Zn 2+ and appropriate pH (7.5-9.5), and the level of ADAMTS-12 in the cartilage and synovium of patients with both osteoarthritis and rheumatoid arthritis is significantly higher than in normal cartilage and synovium. Together, these findings indicate that ADAMTS-12 is a new COMP-interacting and -degrading enzyme and thus may play an important role in the COMP degradation in the initiation and progression of arthritis.
More than 15% of the world population older than 18 years are affected by arthritic disorders, including osteoarthritis (OA) and rheumatoid arthritis (RA) (1) . Accumulating evidence suggests that proteases perform an important function in the breakdown of the extracellular matrix in OA and RA (2) . Cartilage oligomeric matrix protein (COMP), a prominent noncollagenous component of cartilage, accounts for approximately 1% of the wet weight of articular tissue (3, 4) . COMP is a 524-kDa pentameric, disulfide-bonded, multidomain glycoprotein composed of approximately equal subunits (~110 kDa each) (5, 6) . Several studies suggest that monitoring of COMP levels (in both joint fluid and serum) can be used to assess the presence and progression of arthritis (7) (8) (9) (10) (11) . Synovial fluid COMP levels were found to be higher in individuals with knee pain or injury (12) , anterior cruciate ligament or meniscal injury (9, 12) , OA (8, 12) , and RA (7,13) than in healthy individuals.
Fragments of COMP have been detected in the cartilage, synovial fluid, and serum of patients with posttraumatic and primary OA and RA (7, 8, 13 ). The molecular mechanism of COMP degradation and the enzyme (s) responsible for it, however, remain largely unknown. Theoretically, inhibition of degradative enzymes can slow down or block the initiation and progression of arthritic diseases. The isolation of cartilage degradative enzymes is therefore of great interest from both a pathophysiological and a therapeutic standpoint.
The ADAMTS family (ADAMTS: a disintegrin and metalloprotease with thrombospondin motifs) consists of secreted zinc metalloproteinases with a precisely ordered modular organization that includes at least one thrombospondin type I repeat (14, 15) . Important functions have been established for several members of the ADAMTS family. ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-8 degrade the cartilage proteoglycan aggrecan and play a major role in aggrecan loss in arthritis (16) (17) (18) (19) (20) (21) . ADAMTS-5 was shown to be the major aggrecanase in mouse cartilage in vivo (22, 23) . ADAMTS-1 and ADAMTS-4 also participate in the turnover of the proteoglycans versican and brevican in blood vessels (24) and the nervous system, respectively (25) . ADAMTS-2, ADAMTS-3, and ADAMTS-14 are procollagen N-propeptidases (26, 27) . ADAMTS-2 mutations cause dermatosparaxis, an inherited disorder characterized by severe skin fragility (28) . ADAMTS-13 is a von Willebrand factor-cleaving protease, and its mutations lead to heritable lifethreatening thrombocytopenic purpura (29) (30) (31) (32) (33) . Several other ADAMTS enzymes whose functions are presently unknown, including ADAMTS-12, have been discovered through molecular cloning and classified as orphan ADAMTS. Expression profile analysis of the ADAMTS family in cartilage revealed that ADAMTS-12 is significantly higher in OA patients than in normal controls (1) , indicating that ADAMTS-12 is probably an important enzyme that causes cartilage degradation in arthritic disorders.
In this study we report the identification of ADAMTS-12 as a novel metalloproteinase known to bind to (through specific molecular domains for each binding partner) and degrade COMP. The relevance of this interaction is exemplified by the upregulation of ADAMTS-12 mRNA in arthritic cartilage and synovium.
EXPERIMENTAL PROCEDURES

Plasmid constructs
Yeast expression vectors pDBleu and pPC86 were obtained from Life Technologies (Gaithersburg , MD). The segment encoding the four functional domains of mouse COMP-the N-terminal (a.a. 20-83), EGF repeat domain (a.a. 84-261), type III repeat domain (a.a. 266-520), and C-terminal domain (a.a. 521-755; GenBank accession number AF257516)-were amplified by PCR and cloned in-frame into the SalI/NotI sites of pDBleu to generate pDB-COMP-NT, pDB-COMP-EGF, pDB-COMP-type III, and pDB-COMP-CT yeast expression constructs.
cDNA inserts encoding the following fragments of human ADAMTS-12 (See Fig. 4 The bacterial expression vector pGEX-3X (Life Technologies) was used to produce recombinant GST fusion proteins in Escherichia coli. The cDNA fragments encoding the catalytic domain of hADAMTS-12 (a.a. 241-463, Genbank accession number AJ250725) and the EGF-like domain of COMP (a.a. 84-261) were inserted in-frame into the BamHI/EcoRI sites of pGEX-3X to generate the pGEX12-CD and pGEX-COMP-EGF plasmids. The bacterial expression pBAD TOPO vector (Invitrogen, Carlsbad, CA) was used to produce His-tagged proteins in E. coli. A cDNA segment encoding the four C-terminal TSP motifs (His-TS12C4TSP) of hADAMTS-12 (a.a.1316-1530) was subcloned into the pBAD TOPO vector per the manufacturer's protocol.
All constructs were verified by nucleic acid sequencing; subsequent analysis was performed using Curatools (Curagen, New Haven, CT) and BLAST software (available at http://www.ncbi.nlm.nih.gov/BLAST/).
Expression and purification of glutathione Stransferase (GST) and His-tagged proteins
For expression of GST fusion proteins, the pGEX12-CD and pGEX-COMP-EGF plasmids were transformed into E. coli DH5α (Life Technologies). Fusion proteins were affinitypurified on glutathione-agarose beads as previously described (34) . To cleave off and remove the GST moiety from the GST fused catalytic domain of ADAMTS-12, 50 µg of purified GST-TS12-CD fusion protein was incubated with 1 µg of Xa factor (New England Biolabs, Beverly, MA) in 20 µl of 20mM Tris-HCl (pH 8.0), 100mM NaCl, 2mM CaCl 2 at 23°C for 8 h. The reaction was terminated by the addition of 2µM dansyl-Glu-Gly-Arg-chloromethyl ketone (New England Biolabs) and incubated at room temperature for 1 min. The completion of the cleavage was established by SDS-PAGE and the resultant GST moiety was removed using glutathione-Sepharose-4B beads (Amersham, Piscatway).
His-TS12C4TSP was purified by affinity chromatography using a HiTrap chelating column (Amersham Pharmacia Biotech, Uppsala, Sweden). Briefly, bacteria lysates supplemented with 20mM HEPES (pH 7.5) and 0.5M NaCl were applied to the HiTrap chelating column, the column was washed with HSB buffer (40mM HEPES, pH 7.5, 1M NaCl, 0.05% Brij 35) containing 10mM imidazole, and the His-TS7C4TSP was eluted with HSB buffer containing 300mM imidazole.
Assay of protein-protein interactions using the Y2H system
Three independent colonies were analyzed for interaction in yeast of two proteins, one of which was fused to the Gal4 DNA binding domain and the other to the VP16 transactivation domain. 
In vitro digestion assay
To determine whether ADAMTS-12 can digest COMP in vitro, a cotransfection assay was performed. Briefly, a COMP stable line was transfected with either control or expression constructs encoding wild-type ADAMTS-12 (pcDNA3-ADAMTS12-HA-Flag) or ADAMTS-12 with mutant catalytic domain (pcDNA3-ADAMTS12-MUT) (39) . Seventy-two hours after transfection, the media were collected and subjected to 8% nonreduced SDS-PAGE and intact COMP, and fragments were detected by western blotting with polyclonal rabbit anti-COMP antiserum, as previously described (13, 37, 38 ). An in vitro digestion assay with purified COMP and the cell lysates carrying ADAMTS-12 was then performed. Briefly, purified COMP (200nM) was incubated with the cell lysates and medium prepared from COS-7 or HEK293 cells transfected with the abovementioned plasmids in a digestion buffer (50mM Tris-HCl, 100mM NaCl, 5mM CaCl 2 , 2mM ZnCl 2 0.05% Brij-35, pH 7.5) at 37°C for 12 h. The digested products were analyzed as described above. Finally, we examined the degradation of COMP mediated by purified ADAMTS-12.
Briefly, medium was collected from COS-7 or HEK293 cells transfected with the abovementioned plasmids and 50 µl of anti-Flag M2 antibody (Sigma) was added to the medium followed by 50 µl of protein A-agarose. After washing, purified ADAMTS-12 was incubated with purified COMP and the digestion performed as described above.
To determine whether the enzymatic activity of ADAMTS-12 depends on divalent cations, purified COMP substrate (250nM) was incubated with purified catalytic domain of ADAMTS-12 (25nM) in digestion buffer (50mM Tris-HCl, 100mM NaCl, pH 7.5) supplemented with 5mM CaCl 2 , 2mM ZnCL 2 , 2.5mM MgCl 2 , 5mM EDTA or various combinations at 37°C for 12 h. The digested products were resolved by 10% nonreduced SDS-PAGE and the gel were stained with Coomassie Brilliant Blue G-Colloidal solution.
To test the enzymatic activity of ADAMTS-12 in the presence of different amount of Zn 2+ or at different pHs, the same digestion was performed in a buffer (50mM Tris-HCl, 100mM NaCl, 5mM CaCl 2 , 2.5mM MgCl 2 ) containing various concentration of Zn 2+ ( 0, 0.5mM, 1.0mM, 2.0mM, 4.0mM 8.0mM) or in a buffer (50mM Tris-HCl, 100mM NaCl, 5mM CaCl 2 , 2.0mM Zn Cl 2, 2.5mM MgCl 2 ) at various pH values (4.5, 5.5, 6.5, 7.5, 8.5, 9.5, 10.5, 11.5) at 37°C for 12 h and digested proteins were processed as above.
RNA preparation and reverse transcription PCR
Human meniscus, bone, cartilage, synovium, ligament, tendon, fat, and skeletal muscle obtained from four normal human knees (provided by the Musculoskeletal Transplant Foundation, Edison, NJ), were frozen immediately after isolation and ground under liquid nitrogen (41) . Total RNA was extracted by the acid-guanidium thiocyanatephenol-chloroform single-step method followed by RNAeasy kit (Qiagen, Valencia, CA).
One microgram of total RNA per sample was reverse-transcribed using the ImProm-II Reverse Transcription system (Promega, Madison, WI). The following sequence-specific primers were synthesized: 5´-GTGGAACGGGAACTATAAGCTG-3´ and 5´-GTTTCAGAACTCTCCGGCTAGA-3´ for human ADAMTS-12
The following pair of oligonucleotides was used as internal controls: 5´-TGAAGGTCGGAGTCAACGGATTTGGT-3´ and 5´-CATGTGGGCCATGAGGTCCACCAC-3´ for human GAPDH PCR was performed for 35 cycles (94ºC 1 min, 60ºC 1 min, and 72 º C 1 min) with a final elongation for 10 min at 72ºC. GAPDH was also amplified as an internal control for 35 cycles (94ºC 1 min, 55ºC 1 min, 72ºC 1.5 min). The PCR product was analyzed by 1% agarose gel electrophoresis and further sequenced by the Applied Biosystems sequencing system (Foster City, CA). (43) .
Expression of ADAMTS-12 in arthritic tissues
Following total RNA extraction and reverse transcription, real-time PCR was performed using a sequence-specific probe and primers for ADAMTS-12 (fluorescence-labeled oligonucleotide probes [using 6-carboxyfluorescein (FAM)] probe: AGGACATCTGTGCTGGTTTCAATCGCC; primers: CACGACGTGGCTGTCCTTCT and CCGAATCTTCATTGATGTTACAACTG). The correction of the PCR products obtained was confirmed by direct sequencing of the amplicons. A standard curve with copy numbers ranging from 10 3 to 10 9 was produced using human cartilage cDNA as the template. An XY scatter plot was produced using Microsoft Excel software, and the equation y = mx + b (where m = the slope of the standard curve and b = the y-intercept of that line) was calculated and R 2 values obtained. As an internal control, 18s rRNA was analyzed in parallel by using the Endogenous Control Human rRNA kit (Applied Biosystems, Foster City, CA).
PCR reactions for all samples were performed in duplicate in 96-well optical plates with 5 ng of cDNA (1 ng of cDNA for the 18S rRNA), 100 nM probe, 200 nM each primer, and 10.0 µl of TaqMan Universal 2× PCR Master Mix (PEApplied Biosystems, St. Louis, MO) in a 20-µl reaction volume. The amplification reaction was carried out over 40 cycles (an initial holding stage of 2 min at 50°C and then 10 min at 95°C, followed by a two-step cycling program of 15 s at 95°C and 1 min at 60°C).
RESULTS
ADAMTS-12 associates with COMP in yeast
Our unpublished observation that the EGF-like domain of COMP binds to the C-terminal TSP1-like repeats of ADAMTS-7, whose domain organization and structure are similar to those of ADAMTS-12, prompted us to investigate whether ADAMTS-12 interacts with COMP. For this purpose, the four C-terminal TSP1-like repeats of ADAMTS-12 (a.a. 1316-1530) were subcloned into a yeast expression pPC86 vector and a yeast two-hybrid (Y2H) assay performed (Fig. 1A) . Briefly, the plasmid encoding the EGF-like domain of COMP (a.a. 84-261) linked to Gal4DBD (above the line in Fig. 1B ) and the plasmid encoding the four C-terminal TSP1-like repeats of ADAMTS-12 fused to VP16AD (below the line) were used to cotransform the yeast strain MAV203. Plasmid pairs encoding c-Jun/c-Fos and Rb/lamin were used as positive and negative protein-protein interaction controls, respectively. Interaction between the C-terminal polypeptide of ADAMTS-12 and the EGF-like domain of COMP was resolved by a β-galactosidase assay and growth phenotype on selective media (Fig. 1B) . Like the c-Jun/c-Fos pair, which are known to interact, the EGF-like domain of COMP was shown to interact with the C-terminal of ADAMTS-12 in yeast based on β -galactosidase activity (Fig. 1B, left) and growth inhibition on plates containing 5-fluoroorotic acid (two hybriddependent activation of URA3 results in conversion of 5-fluoroorotic acid to 5-fluorouracil, which is toxic). Hence, the growth of yeast containing interacting proteins is inhibited when plated on the medium containing 5-fluoroorotic acid (Fig. 1B, right) .
Direct binding of COMP to the C-terminal polypeptide of ADAMTS-12 in vitro
The interaction between COMP and ADAMTS-12 was also confirmed using in vitro GST pulldown assays. Briefly, affinity-purified GST and a purified COMP EGF-like domain (a.a. 84-261) as a GST fusion protein (GST-EGF) that were immobilized on glutathione-Sepharose beads were incubated with cell extracts prepared from COS-7 cells transfected with an expression plasmid encoding either wild-type ADAMTS-12 (TS-12, Fig. 2A) or ADAMTS-12 with mutant catalytic domain (TS-12mut, Fig. 2B ) (39) . After washing, glutathione-Sepharose bead bound proteins were resolved by 10% SDS PAGE and western blotting. Purified GST did not pull down either wild-type or mutant ADAMTS-12 ( Fig. 2A, lane 2; Fig. 2B , lane 2), whereas GST-EGF efficiently pulled down these proteins (Fig. 2A, lane 3; Fig. 2B, lane 3) , indicating that the EGF-like domain of COMP binds to the ADAMTS-12 in vitro.
The interaction between COMP and ADAMTS-12 was also characterized by an in vitro solid-liquid phase titration experiment in which the dilution series of recombinant His-TS12C4TSP and purified COMP showed dose-dependent binding and saturation to the liquid-phase COMP (Fig. 2C) . The interaction between COMP and ADAMTS-12 is direct, since both COMP and the C-terminal four TSP-1-like repeats were used as purified recombinant proteins.
Binding of COMP to ADAMTS-12 in mammalian cells
We next performed a coimmunoprecipitation (Co-IP) assay to determine whether ADAMTS-12 associates with COMP in vivo (Fig. 2D) . COMP stable cell lines were transfected with a mammalian expression pcDNA3-ADAMTS12-HA plasmid that encodes HA-tagged ADAMTS-12 (provided by Drs. Cal and Lopez-Otin) (39) . The cell extracts prepared from those transfected cells were first incubated with control IgG (negative control), anti-COMP (positive control), or anti-HA, and the complexes were detected with anti-COMP polyclonal antiserum. A specific COMP band was immunoprecipitated by anti-COMP antibodies (lane 3) and anti-HA antibodies (lane 4), but not by control IgG antibodies (lane 2), demonstrating that ADAMTS-12 specifically associates with COMP in vivo.
Selective association of ADAMTS-12 with the EGF-like domain of COMP
As shown in Fig. 1 , ADAMTS-12 associates with the EGF-like domain of COMP. We also investigated whether ADAMTS-12 interacts with the other three functional domains of COMP, including the N-terminal pentamerizing domain, the type III domain, and the C-terminal global domain. For this purpose, filter-based β-galactosidase assays were performed to determine whether coexpression of the various domains of COMP/Gal4DBD and ADAMTS-12/VP16AD fusion proteins activate the reporter LacZ gene. As shown in Fig. 3 , of the four functional domains tested, ADAMTS-12 selectively interacts with only the EGF-like domain of COMP.
Four C-terminal TSP1-like repeats of ADAMTS-12 are necessary and sufficient for binding COMP
In order to identify the COMP-binding domain in ADAMTS-12, we generated various constructs that expressed various ADAMTS-12 deletion mutants in yeast. Results from filter-based β-galactosidase assays (Fig. 4B ) of all these mutants are summarized in Fig. 4A . The ADAMTS-12 prodomain, the metalloproteinase, disintegrin-like, and cysteine-rich domains , and the spacer-1 plus three TSP repeats all failed to bind to COMP. As expected, the spacer-2 plus four C-terminal TSP-1-like repeats bound to COMP. When the spacer-2 domain was removed, the binding to COMP was not disturbed, indicating that this domain is not required for binding. Further removal of four TSP-1-like repeats eliminated binding, indicating that four TSP-1-like repeats in the C-terminal are required. When four TSP-1-like repeats were used, however, COMP binding occurred. Our conclusion from this set of experiments is that that four C-terminal TSP-1-like repeats of ADAMTS-12 are required and sufficient for its interaction with COMP.
Cleavage of COMP by recombinant ADAMTS-12 in vitro
Once the interaction between ADAMTS-12 and COMP was established, cotransfection assays were performed to determine whether ADAMTS-12 has COMP-degrading activity. A COMP stable line was transfected with empty pcDNA3 vector, wild-type ADAMTS-12 (pFlag-TS-12), or ADAMTS-12 with mutant catalytic domain (pTS12mut), and the media collected and detected by western blotting with anti-COMP antibodies (13,37,38). As shown in Fig. 5A , the COMP stable cells transfected with either empty vector (lane 3) or mutant ADAMTS-12 (in which two crucial amino acids in the catalytic domain of ADAMTS-12 were mutated) (39) (lane 2) did not show any COMP-degrading activity, but wild-type ADAMTS-12 (lane 1) digested COMP and produced one major fragment with an apparent molecular mass of approximately 100 kDa (large arrowhead) and two minor fragments (small arrowheads). We verified the COMP-cleaving activity of ADAMTS-12 by an in vitro digestion assay with purified COMP and the cell lysates expressing ADAMTS-12 or its mutant. As indicated in Fig. 5B , cell extracts transfected with an empty vector (lane 1) did not result in any COMP-degrading activity, but wild-type ADAMTS-12 (lane 2) showed COMP-degrading activity. In addition, enzymatic activity was dramatically reduced when the two crucial amino acids in the catalytic domain of ADAMTS-12 were mutated (39) (lane 3). COMP-degrading activity by ADAMTS-12 was further demonstrated by digestion performed with purified ADAMTS-12 (Fig. 5C ).
Cleavage of COMP by ADAMTS-12 is Zn
2+ -and pH-dependent It was reported that the catalytic domain of ADAMTS-20 produced in bacteria can digest its substrates in vitro (44) . Using a similar method, we purified the catalytic domain (a.a. 241-464) of ADAMTS-12 as a GST fusion protein (GST-TS12-CD) in bacteria. The GST moiety was further removed by a Xa factor, and the purity of proteins was confirmed by silver staining (not shown). The recombinant catalytic domain of ADAMTS-12 was employed in the following in vitro digestion assays. To determine whether ADAMTS-12-mediated COMP cleavage requires the involvement of cations, including Ca 2+ , Zn 2+ , and/or Mg 2+ , purified COMP substrate and ADAMTS-12 enzyme were incubated in digestion buffer in the presence or absence of various cations (Fig. 5D) . A degraded COMP fragment (arrow in Fig. 5D) (Fig. 5E ). The highest enzymatic activity was observed in the presence of 2 mM of ZnCl 2 , and the amount of digested COMP was dramatically reduced or totally abolished in the presence of higher amounts of ZnCl 2 (4 or 8 mM). In vitro digestions were performed at various pH values in order to examine its regulation of ADAMTS-12 activity. As shown in Fig. 5F , ADAMTS-12 generated the largest amount of COMP fragments in the range of physiological pH (pH 7.5) up to pH 9.5, whereas the enzyme did not produce visible COMP fragments at pH values lower than 6.5 or higher than 10.5, indicating that the digestive activity of ADAMTS-12 is pHdependent.
Musculoskeletal tissues distribution of ADAMTS-12
The fact that COMP is predominately expressed in the musculoskeletal tissues, together with our findings that ADAMTS-12 binds to and cleave COMP, prompted us to test the expression of ADAMTS-12 in musculoskeletal tissues. Reversetranscription PCR (RT-PCR) assay was performed to examine the expression of ADAMTS-12 mRMNA in eight specimens of normal human musculoskeletal tissue. As seen in Fig. 6A , the 733-bp hADAMTS-12 fragment was amplified using ADAMTS-12-specific primers from cartilage, synovium, and tendon in which COMP was also present (4, 45) . ADAMTS-12 is also detectable in skeletal muscle and fat. However, ADAMTS-12 was undetectable in meniscus, bone, and ligament. These results demonstrate that while ADAMTS-12 is coexpressed in COMP-producing musculoskeletal tissues, it has a wider tissue distribution (3, 4, 38, 46) .
Increased expression of ADAMTS-12 in the cartilage and synovium of patients with arthritis
To determine whether the expression of ADAMTS-12 in cartilage and synovium is altered in OA or RA, a quantitative real-time PCR was performed using a sequence-specific probe and primers for ADAMTS-12. Total RNA was extracted from adult age-matched normal and arthritic tissues (articular cartilage and synovium). As shown in Fig. 6B , ADAMTS-12 mRNA was significantly upregulated in both OA and RA cartilage (p < .05 and p <.001, respectively) compared to the normal control. Further analysis of synovium samples revealed that the level of ADAMTS-12 was also significantly upregulated in RA synovium compared to normal synovium (p < .001; Fig. 6C ).
DISCUSSION
The present study demonstrates that ADAMTS-12 binds to the EGF-like repeat domain of COMP via its four C-terminal TSP-1 like repeats and that ADAMTS-12-mediated COMP degradation is Zn 2+ -and pH-dependent (Figs. 3, 4, 5) . In view of the fact that prominent COMP degradative fragments in OA and RA are produced by cleavage within COMP's EGF-like molecular domain, the binding of ADAMTS-12 to this same region with subsequent COMP cleavage is strong evidence that ADAMTS-12 plays an important role in COMP degradation (13).
COMP interacts with multiple protein partners; these interactions are important for COMP's physiologic functions and cytoplasmic processing and transport. COMP can mediate chondrocyte attachment through interactions with integrins. Through these interactions, COMP may be able to regulate cellular activities and respond to environment in the surrounding cartilage matrix (3, 47) . Several reports suggest that COMP may function to stabilize the articular cartilage extracellular matrix by specific cation-dependent interactions with matrix components, including collagen types II and IX, fibronectin, aggrecan, and matrilin-1, -3, and -4 (10,48-51). COMP has also been shown to associate with several chaperone proteins, including BiP, calreticulin, protein disulfide, ERp72, Grp94, HSP47, and calnexin, and it has been proposed that these associations facilitate the processing and transport of wild-type COMP in normal chondrocytes and in the retention of mutant COMP in pseudoachondroplasia chondrocytes (52) (53) (54) . In addition to the interactions between COMP and its protein partners, the five-stranded N-terminal domain of COMP forms a complex with vitamin D-3, illustrating that COMP has storage function for hydrophobic compounds, including prominent cell-signaling molecules (55) .
Purified COMP has been reported to be digested in vitro by several members from the family of matrix metalloproteinases (MMPs), including interstitial collagenase (MMP-1), collagenase-3 (MMP-13), stromelysin-1 (MMP-3), gelatinase-B (MMP-9), MMP-19, and enamelysin (MMP-20) (56) . It was also shown that ADAMTS-4 is able to cleave purified COMP in an in vitro digestion assay and that the resultant fragment has a molecular mass similar to one of the fragments observed in OA and RA samples (57) ; all these assays, however, were performed using an in vitro digestion system in which both enzymes and substrates were at higher concentrations than those in physiological/pathological conditions. None of these metalloproteinases has been found capable of associating with COMP, which is probably necessary for COMP degradation in vivo. Results from this study using ADAMTS-12 comprehensive protein-protein interactions and enzymatic activities assays clearly show that ADAMTS-12 can bind to and cleave COMP (Figs.  1-5) .
The C-terminal domain of metalloproteinases were found to be important for binding substrates and determining enzyme selectivity; data from chimeric constructs indicate that collagenases, stromelysins, and gelatinases interact with their macromolecular substrates via this domain [see the review by Martel Pelletier (62)]. The matrixbinding properties of ADAMTS-1 appear to be related to the number of TSP repeats in its Cterminal region (63) , and our finding that four Cterminal TSP repeats of ADAMTS-12 are required and sufficient for binding to COMP also supports this concept. Recent studies also provide evidence that ADAMTS-4 interacts with aggrecan via its cysteine-rich/spacer domains (64), whereas its Cterminal region plays a major role in regulating aggrecanase activity by masking its general proteolytic activity (65) .
In addition to their substrates, the enzymatic activities of ADAMTS proteins may be regulated by their associated proteins, and several ADAMTS-binding partners have been isolated. α2-Macroglobulin was found to form protein complexes with ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes (58) . It was also reported that the aggrecanase activity of ADAMTS-4 is inhibited by fibronectin through interaction with its Cterminal domains, suggesting that this extracellular regulation mechanism of ADAMTS-4 activity may be important for the degradation of aggrecan in arthritic cartilage (59) . ADAMTS-4 also associates with α1-antitrypsin a member of the family of plasma serine proteinase inhibitors, but the physiological significance of the interaction between them remains unclear (60) .The extracellular matrix protein fibulin-1 was identified as an ADAMTS-1 interacting molecule in a yeast-two-hybrid screen, and fibulin-1 was found to enhance the capacity of ADAMTS-1 to cleave aggrecan, indicating that fibulin-1 is a regulator of ADAMTS-1-mediated proteoglycan proteolysis and thus may play an important role in proteoglycan turnover (61) .
As shown in Fig. 5D and E, the COMPdegrading activity of ADAMTS-12 depends on the presence of appropriate cations; this dependence was further verified with EDTA chelator, since 5mM EDTA totally abolished COMP-digestion mediated by ADAMTS-12 (not shown). ADAMTS-12 demonstrated highest enzymatic activities in the presence of 2mM Zn 2+ , whereas most metalloproteinases usually require lower concentrations of Zn 2+ for cleaving their substrates (e.g., 0.1 mM). The differences in metal requirements between metalloproteinases may indicate a difference in the cation dependence of these enzymes. A good example in this regard is the matrix metalloproteinases-gelatinases. The 68K and 130K gelatinases are active at higher concentration of Zn2+ (2 mM), but 60K gelatinase is active at a very low concentration of Zn2+ (5 μM) (66).
Reverse-transcription PCR was employed to examine the expression of ADAMTS-12 in human musculoskeletal tissues and revealed that ADAMTS-12 is expressed in COMP-expressing tissues, including cartilage, synovium, and tendon (Fig.6A) . A real-time PCR assay performed to compare the expression profile of the ADAMTS genes in OA and normal cartilage showed that ADAMTS-12 mRNA was significantly upregulated in OA cartilage (p < .05) (1). This finding is in agreement with our quantitative realtime PCR assays using OA cartilage; we also found, however, that ADAMTS-12 is significantly upregulated in cartilage and synovium obtained from patients with RA (p < .001, Fig. 6B and C) , suggesting that ADAMTS-12 plays an important role in joint degenerative disease progression. The increased expression of ADAMTS-12 in the joint tissues of arthritic patients may be due to proinflammatory cytokines, including TNF-α  and IL-1β (not shown).
Our identification of ADAMTS-12 as a COMPbinding protein and subsequent characterization of the enzyme/substrate association and COMP degradation mediated by ADAMTS-12 significantly extend our understanding of the degradative events that occur in joint disorders and promise to increase our ability to monitor the biological and physical properties of cartilage extracellular matrix. Since the levels of ADAMTS-12 are significantly increased in the cartilage and synovium of arthritis patients, this enzyme appears to play an important role in the pathophysiology of cartilage degradation in arthritis.
proteins fused to the VP16 AD and proteins fused to the Gal4 DBD. Each pair of plasmids, as indicated, encoding proteins fused to VP16 (below the line) in the vector pPC86 (i.e., pPC86-c-jun, pPC86-ADAMTS-12, and pPC86-Rb) and those encoding proteins fused to Gal4 (above the line) in the vector pDBleu (i.e., pDB-c-fos, pDB-COMP, and pDB-lamin) were cotransfected into yeast strain MAV203. Yeast transformants were selected on SD-leu /trp plates and tested for β-galactosidase activity (left panel) and for growth on plates containing 5-fluoroorotic acid (5FOA) (right panel, SD-leu /trp /5FOA + ). The known interaction between c-Jun and c-Fos is used as a positive control, and the lack of interaction between Rb and lamin as a negative control. -12 (pFlag-TS12, lane 3) or ADAMTS-12 mutant (pTS-12mut, lane 2), followed by addition of protein A-agarose. Purified ADAMTS-12 or its mutant was incubated with purified COMP, and the digestion was performed as described in (B). (D) To demonstrate that Zn 2+ is essential for the enzymatic activity of ADAMTS-12, purified COMP was incubated with purified catalytic domain of ADAMTS-12 in a digestion buffer supplemented with 5mM CaCl 2 , 2mM ZnCL 2 , 2.5mM MgCl 2 , or a combination of these, as indicated; the digested proteins were resolved by 10% nonreduced SDS-PAGE and the gel stained with Coomassie Brilliant Blue G-Colloidal Solution. The large arrow indicates the resultant fragment; the small arrow indicates the additional (lower) band in lane 8, which is probably due to the conformation change in the presence of Ca 2+ .
(E) To demonstrate that ADAMTS-12 activity depends on the appropriate concentration of Zn 2+ , the same digestion was performed in a buffer (50mM Tris-HCl, 100mM NaCl, 5mM CaCl 2 , 2.5mM MgCl 2, pH7.5) containing various concentration of Zn 2+ (0, 0.5, 1.0, 2.0, 4.0, or 8.0 mM), as indicated; digested proteins were resolved as in (D). (F) To demonstrate that the activity of ADAMTS-12 is pH-dependent, the same digestion was performed in a buffer supplemented with 5mM CaCl 2 , 2mM ZnCL 2 , and 2.5mM MgCl 2 at various pH values, as indicated; digested proteins were resolved as in (D). by guest on November 15, 2017 
